Is ten dollars a share (just to use a number mentioned in another post) or five dollars a share unreasonable if most or all of the 12 patients in the trial are helped by Actc. I am not looking for a crystal ball answer but would appreciate any input from those more knowledgeable-- what is the worth/mkt cap for a company that succeeds in stopping/potentially reversing blindness for millions of people? Perhaps i am being too simplistic, but if Lanza helped some rats with human cells-- I expect that he can do the smae for people. gotta be worth a fortune???Please forgive my lack of financial/scientic expertise--I make no claims as a financial/scientific guru--just wondering though? Thank you and GLTA longs
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.